Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1

Chinese Medical Journal

Volumn 120, Issue 8, 2007, Pages 703-707

  Chen, Yong Bing ^a,c,d   Yan, Mao Lin ^b   Gong, Jian Ping ^a   Xia, Ren Pin ^c   Liu, Li Xin ^b   Li, Ning ^c   Lu, Shi Chun ^c   Zhang, Jing Guang ^c   Zeng, Dao Bing ^c   Xie, Jian Guo ^b   Yang, Jia Yin ^b   Yan, Lü Nan ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Carcinoma, hepatocellular; Drug resistance, multiple; P glycoprotein

Indexed keywords

COMPLEMENTARY DNA; DAUNORUBICIN; DNA FRAGMENT; DOXORUBICIN; GLYCOPROTEIN P; LIPOSOME; MESSENGER RNA; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN 1; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN HEPG2; CLUSTER ANALYSIS; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER CELL CARCINOMA; MOLECULAR CLONING; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME;

EID: 34248642890     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200704020-00017     Document Type: Article

References (30)

1. Chang G, Roth CB. Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science 2001; 293: 1793-1800.
2. Lasagna N, Fantappie O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, et al. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Cancer Res 2006; 66: 2673-2682.
3. Barraud L, Merle P, Soma E, Lefrancois L, Guerret S, Chevallier M, et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol 2005; 42: 736-743.
4. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003; 348: 1442-1448.
5. 99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression. Hepatogastroenterology 2004; 51: 211-214.
6. Gan HZ, Zhang GZ, Zhao JS, Zhang FC, Bu LS, Yang SJ, et al. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Chin Med J 2005; 118: 893-902.
7. Ramachandran C, Wellham LL. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts. Anticancer Res 2003; 23: 2681-2690.
8. Li B, Gou XH, Chen L, Li DH, Zhao YH, Han L, et al. Constructi,on of the recombinant adenovirus vector carrying antisense multidrug resistance gene. Hepatobiliary Pancreat Dis Int 2006; 5: 80-84.
9. Guo CB, Li YC, Jin XQ. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo. Cancer Chemother Pharmacol 2006; 58: 40-49.
10. Zhang YS, Yuan FJ, Jia GF, Zhang JF, Hu LY, Huang L, et al. CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R. World J Gastroenterol 2005; 11: 3339-3345.
11. Yang XD, Tang DN, Wang J, Cao DL. Screening of the drug resistance-associated gene in HepG2 cell line transfected with aldose reductase like gene-1 (ARL-1). Cancer 2003; 22: 1289-1295.
12. Kakumoto M, Takara K, Sakaeda T, Tanigawara Y, Kita T, Okumura K. MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs. Biol Pharm Bull 2002; 25: 1604-1607.
13. Kanzaki A, Takebayashi Y, Ren XQ, Miyashita H, Mori S, Akiyama S, et al. Overcoming multidrug drug resistance in P-glycoprotein/ MDR1-overexpressing cell lines by ecteinascidin 743. Mol Cancer Ther 2002; 1: 1327-1334.
14. Grude P, Conti F, Mennecier D, Louvel A, Houssin D, Weill B, et al. MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis. Cancer Lett 2002; 186: 107-113.
15. Barakat S, Gayet L, Dayan G, Labialle S, Lazar A, Oleinikov V, et al. Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis. Biochem J 2005; 388 (Pt 2): 563-571.
16. Oda Y, Saito T, Tateishi N, Ohishi Y, Tamiya S, Yamamoto H, et al. ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas. Ent J Cancer 2005; 114: 854-862.
17. Sorrentino BP, McDonagh KT, Woods D, Orlic D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 1995; 86: 491-501.
18. Schwarzenberger P, Spence S, Lohrey N, Kmiecik T, Longo DL, Murphy WJ, et al. Gene transfer of multidrug resistance into factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection. Blood 1996; 87: 2723-2731.
19. Licht T, Herrmann F, Gottesman MM, Pastan I. In vivo drug-selectable genes: a new concept in gene therapy. Stem Cells 1997; 15: 104-111.
20. Licht T, Haskins M, Henthorn P, Kleiman SE, Bodine DM, Whitwam T, et al. Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrow. Proc Natl Acad Sci USA 2002; 99: 3123-3128.
21. Higashi K, Ueda Y, Ikeda R, Kodama Y, Guo J, Matsunari I, et al. P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer. Nucl Med Commun 2004; 25: 19-27.
22. Goto M, Masuda S, Saito H, Ogura Y, Oike F, Okuda M, et al. Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2. Biochem Pharmacol 2003; 66: 163-170.
23. Hunter HM, Pallis M, Seedhouse CH, Grundy M, Gray C, Russell NH. The expression of P-glycoprotein in AML cells with FLT3 internal tandem duplications is associated with reduced apoptosis in response to FLT3 inhibitors. Br J Haematol 2004; 127: 26-33.
24. Findling-Kagan S, Sivan H, Ostrovsky O, Nagler A, Galski H. Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1. Leuk Res 2005; 29: 407-414.
25. Landowski TH, Gleason-Guzman MC, Dalton WS. Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 1997; 89: 1854-1861.
26. Yang LY, Trujillo JM. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods. Cancer Res 1990; 50: 3218-3225.
27. Fu J, Chen Z, Cen J, Ruan C. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists. Chin Med J 2000; 113: 228-231.
28. Huesker M, Folmer Y, Schneider M, Fulda C, Blum HE, Hafkemeyer P. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes. Hepatology 2002; 36 (4 Pt 1): 874-884.
29. Wang H, Chen XP, Qiu FZ. Overcoming multi-drug resistance by anti-MDR1 ribozyme. World J Gastroenterol 2003; 9: 1444-1449.
30. Jin J, Wang FP, Wei H, Liu G. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Cancer Chemother Pharmacol 2005; 55: 179-188.